Cargando…

Add-On Therapies in Cardiovascular Disease: Reviewing ICER’s Report and the Potential Effect on Payers

Detalles Bibliográficos
Autores principales: Magness, Jonathan W., Arnwine, Caitlin, Lockwood, Kelsey, Reinert, Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391064/
https://www.ncbi.nlm.nih.gov/pubmed/32463778
http://dx.doi.org/10.18553/jmcp.2020.26.6.786
_version_ 1785082616934825984
author Magness, Jonathan W.
Arnwine, Caitlin
Lockwood, Kelsey
Reinert, Amber
author_facet Magness, Jonathan W.
Arnwine, Caitlin
Lockwood, Kelsey
Reinert, Amber
author_sort Magness, Jonathan W.
collection PubMed
description
format Online
Article
Text
id pubmed-10391064
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103910642023-08-02 Add-On Therapies in Cardiovascular Disease: Reviewing ICER’s Report and the Potential Effect on Payers Magness, Jonathan W. Arnwine, Caitlin Lockwood, Kelsey Reinert, Amber J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2020-06 /pmc/articles/PMC10391064/ /pubmed/32463778 http://dx.doi.org/10.18553/jmcp.2020.26.6.786 Text en Copyright © 2020, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Perspectives on Value
Magness, Jonathan W.
Arnwine, Caitlin
Lockwood, Kelsey
Reinert, Amber
Add-On Therapies in Cardiovascular Disease: Reviewing ICER’s Report and the Potential Effect on Payers
title Add-On Therapies in Cardiovascular Disease: Reviewing ICER’s Report and the Potential Effect on Payers
title_full Add-On Therapies in Cardiovascular Disease: Reviewing ICER’s Report and the Potential Effect on Payers
title_fullStr Add-On Therapies in Cardiovascular Disease: Reviewing ICER’s Report and the Potential Effect on Payers
title_full_unstemmed Add-On Therapies in Cardiovascular Disease: Reviewing ICER’s Report and the Potential Effect on Payers
title_short Add-On Therapies in Cardiovascular Disease: Reviewing ICER’s Report and the Potential Effect on Payers
title_sort add-on therapies in cardiovascular disease: reviewing icer’s report and the potential effect on payers
topic Perspectives on Value
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391064/
https://www.ncbi.nlm.nih.gov/pubmed/32463778
http://dx.doi.org/10.18553/jmcp.2020.26.6.786
work_keys_str_mv AT magnessjonathanw addontherapiesincardiovasculardiseasereviewingicersreportandthepotentialeffectonpayers
AT arnwinecaitlin addontherapiesincardiovasculardiseasereviewingicersreportandthepotentialeffectonpayers
AT lockwoodkelsey addontherapiesincardiovasculardiseasereviewingicersreportandthepotentialeffectonpayers
AT reinertamber addontherapiesincardiovasculardiseasereviewingicersreportandthepotentialeffectonpayers